About AOD-9604 Store

What this site is

AOD-9604 Store is an independent editorial project that publishes summaries of the peer-reviewed research literature on AOD-9604. We are not a clinic. We do not employ clinicians, and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The word "Store" in the name is not a checkout. We read it as a store of knowledge — a place where the AOD-9604 research is gathered, organised, and explained in plain words. It is a position this publisher takes relative to the literature, not a claim about any service. You will not find a price, a cart, or an order form here, and the negative terms people often search alongside this compound — buying, sourcing, dosage calculators — are deliberately not part of what we publish.

How we write

Two habits shape everything here. First, plain English leads: each technical page opens with a short, jargon-free summary a non-scientist can read straight through, and the full depth follows beneath it. Second, honesty about the evidence: we tag every finding as preclinical or human, and we lead with the result that matters most — for AOD-9604, that the pivotal human obesity trial did not beat placebo. We do not overclaim, we do not recommend doses, and we do not use brand names for other compounds. Every quantitative statement is cited to a source you can check.

Why the honesty matters here

AOD-9604 is a compound whose marketing has badly outrun its evidence. The internet is full of "fat-loss peptide" claims, while the single most important fact — a failed human trial — is rarely mentioned. An editorial digest is most useful exactly when the easy story and the true story diverge. That is the gap this site exists to close: keeping the strong rodent mechanism, the null human result, and the receptor-sparing design all in view at once, so a reader leaves with an accurate picture rather than a marketing one.